Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OMEROS CORPOMER · Entity 4756 | Director · Chairman, CEO & President | July 22, 2026 | July 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OMEROS CORP
Report date July 22, 2026 · Filed July 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.84 · Expires 2036-07-22 | Direct | 1,000,000 |
Reported balance
After 2026-07-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-22 · Grant · Acquired 1,000,000 · Balance 1,000,000 F1: One-third of the total number of shares subject to the option will vest and become exercisable on August 1, 2027. The remaining shares shall vest in 32 equal monthly installments on the first day of each month thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: One-third of the total number of shares subject to the option will vest and become exercisable on August 1, 2027. The remaining shares shall vest in 32 equal monthly installments on the first day of each month thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 05, 2016 Filed Dec 8, 2016 02:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 102,040 | $0.98 | $99,999.20 |
DisclosureSEC source: 0000899243-16-035087 · doc4.xml · nonDerivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,987,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2016 Filed Dec 3, 2016 02:40 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 181,163 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0000899243-16-034882 · doc4.xml · derivative · entry 12 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 181,163 shares Expires 2016-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested and became exercisable in 48 equal monthly installments. The first installment became exercisable on March 28, 2005 and subsequent installments became exercisable on each monthly anniversary thereafter. F7 · derivative.exercise_date: On December 2, 2016, the reporting person exercised incentive stock options to purchase 181,163 shares of common stock, which are being retained by the reporting person. Read SEC document |
| December 02, 2016 Filed Dec 3, 2016 02:40 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 102,040 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0000899243-16-034882 · doc4.xml · derivative · entry 11 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,124 Underlying: Common Stock · 102,040 shares Expires 2016-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested and became exercisable in 48 equal monthly installments. The first installment became exercisable on March 28, 2005 and subsequent installments became exercisable on each monthly anniversary thereafter. Read SEC document |
| December 02, 2016 Filed Dec 3, 2016 02:40 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 181,163 | $0.98 | $177,539.74 |
DisclosureSEC source: 0000899243-16-034882 · doc4.xml · nonDerivative · entry 8 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,884,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2016 Filed Dec 3, 2016 02:40 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 102,040 | $11.00 | $1,122,593.06 |
DisclosureSEC source: 0000899243-16-034882 · doc4.xml · nonDerivative · entry 7 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,703,822 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person that provides for the exercise and sale of options to purchase 612,244 shares of common stock that expire on December 11, 2016 and 100 shares of common stock that expire on April 7, 2020; the latter at a threshold price of $100.00 per share. Under the plan, the options expiring on December 11, 2016, which do not provide for an extension of the exercise period, would be exercised and sold during fixed sale periods at specified prices and numbers in each sale period. Consistent with the applicable trading rules, the reporting person has had no further control over the terms or timing of sales under the plan. A portion of the proceeds from the exercise of the options expiring on December 11, 2016, all of which are non-qualified, are being used in part to fund the reporting person's exercise of all incentive stock options that otherwise would expire on December 11, 2016. See note (7) below. F5 · price: This transaction was executed in multiple trades at prices ranging from $10.84 to $11.30; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| December 02, 2016 Filed Dec 3, 2016 02:40 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 102,040 | $0.98 | $99,999.20 |
DisclosureSEC source: 0000899243-16-034882 · doc4.xml · nonDerivative · entry 6 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,805,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2016 Filed Dec 3, 2016 02:40 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 106,521 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0000899243-16-034882 · doc4.xml · derivative · entry 10 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,164 Underlying: Common Stock · 106,521 shares Expires 2016-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested and became exercisable in 48 equal monthly installments. The first installment became exercisable on March 28, 2005 and subsequent installments became exercisable on each monthly anniversary thereafter. Read SEC document |
| December 01, 2016 Filed Dec 3, 2016 02:40 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 999 | $12.32 | $12,302.69 |
DisclosureSEC source: 0000899243-16-034882 · doc4.xml · nonDerivative · entry 5 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,703,822 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person that provides for the exercise and sale of options to purchase 612,244 shares of common stock that expire on December 11, 2016 and 100 shares of common stock that expire on April 7, 2020; the latter at a threshold price of $100.00 per share. Under the plan, the options expiring on December 11, 2016, which do not provide for an extension of the exercise period, would be exercised and sold during fixed sale periods at specified prices and numbers in each sale period. Consistent with the applicable trading rules, the reporting person has had no further control over the terms or timing of sales under the plan. A portion of the proceeds from the exercise of the options expiring on December 11, 2016, all of which are non-qualified, are being used in part to fund the reporting person's exercise of all incentive stock options that otherwise would expire on December 11, 2016. See note (7) below. F4 · price: This transaction was executed in multiple trades at prices ranging from $12.27 to $12.37; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| December 01, 2016 Filed Dec 3, 2016 02:40 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 105,522 | $11.56 | $1,219,760.45 |
DisclosureSEC source: 0000899243-16-034882 · doc4.xml · nonDerivative · entry 4 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,704,821 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person that provides for the exercise and sale of options to purchase 612,244 shares of common stock that expire on December 11, 2016 and 100 shares of common stock that expire on April 7, 2020; the latter at a threshold price of $100.00 per share. Under the plan, the options expiring on December 11, 2016, which do not provide for an extension of the exercise period, would be exercised and sold during fixed sale periods at specified prices and numbers in each sale period. Consistent with the applicable trading rules, the reporting person has had no further control over the terms or timing of sales under the plan. A portion of the proceeds from the exercise of the options expiring on December 11, 2016, all of which are non-qualified, are being used in part to fund the reporting person's exercise of all incentive stock options that otherwise would expire on December 11, 2016. See note (7) below. F3 · price: This transaction was executed in multiple trades at prices ranging from $11.27 to $12.26; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| December 01, 2016 Filed Dec 3, 2016 02:40 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 106,521 | $0.98 | $104,390.58 |
DisclosureSEC source: 0000899243-16-034882 · doc4.xml · nonDerivative · entry 3 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,810,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2016 Filed Dec 3, 2016 02:40 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 97,559 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0000899243-16-034882 · doc4.xml · derivative · entry 9 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,685 Underlying: Common Stock · 97,559 shares Expires 2016-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested and became exercisable in 48 equal monthly installments. The first installment became exercisable on March 28, 2005 and subsequent installments became exercisable on each monthly anniversary thereafter. Read SEC document |
| November 30, 2016 Filed Dec 3, 2016 02:40 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 97,559 | $12.21 | $1,191,478.31 |
DisclosureSEC source: 0000899243-16-034882 · doc4.xml · nonDerivative · entry 2 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,703,822 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person that provides for the exercise and sale of options to purchase 612,244 shares of common stock that expire on December 11, 2016 and 100 shares of common stock that expire on April 7, 2020; the latter at a threshold price of $100.00 per share. Under the plan, the options expiring on December 11, 2016, which do not provide for an extension of the exercise period, would be exercised and sold during fixed sale periods at specified prices and numbers in each sale period. Consistent with the applicable trading rules, the reporting person has had no further control over the terms or timing of sales under the plan. A portion of the proceeds from the exercise of the options expiring on December 11, 2016, all of which are non-qualified, are being used in part to fund the reporting person's exercise of all incentive stock options that otherwise would expire on December 11, 2016. See note (7) below. F2 · price: This transaction was executed in multiple trades at prices ranging from $12.06 to $12.59; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| November 30, 2016 Filed Dec 3, 2016 02:40 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 97,559 | $0.98 | $95,607.82 |
DisclosureSEC source: 0000899243-16-034882 · doc4.xml · nonDerivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,801,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.